Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ Singapore-based diagnostics developer and medical laboratory operator, INEX Innovate has contributed an undisclosed sum to leading Hong Kong university - The Chinese University of Hong Kong (CUHK), to collaborate and further research in the field of maternal fetal medicine. The CUHK Department of Obstetrics & Gynaecology (O&G) is world-renowned for its many prominent contributions and high-impact publications in the scientific community, attributed to its pursuit towards advancing the frontiers of knowledge in O&G through clinical, scientific and translational research. This initiative will tap on the research expertise of CUHK to further advance LEXI, a novel fetal cell isolation technology developed by INEX Innovate. LEXI i
Talking about the rising male infertility, Dr Neeta Singh, Professor, Department of Obstetrics & Gynaecology, said that Sperm DNA fragmentation is an important factor for this.
The infertility and the impaired fecundity have been a concern through ages and is rising for various reasons. The prevalence of infertility in the general population is 15 to 20 per cent, as per the Word Health Organisation and the male .